Tracking down gene fusions

Stanford researchers use single-cell statistical modeling method to go after cancer
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
STANFORD, Calif.—Stanford University researchers are looking to track down gene fusions that can drive cancers proliferation and uncover fusions in individual tumor cells. To do that, they have turned to a single-cell statistical modeling method, and a member of the team presented their method during the Bioinformatics and Artificial Intelligence minisymposium at the AACR Virtual Annual Meeting II in June.
In the session, Dr. Roozbeh Dehghannasin, a postdoctoral researcher at the Stanford School of Medicine, described the statistical model designed to detect gene fusions at a single-cell level, explaining that many gene fusions are known to drive cancer development, but limitations in current technologies have hindered fully understanding their functions.
Continue reading below...
An illustration showing red cancer cells surrounded by white immune cells interacting on a dark textured background.
ExplainersWhy does immunotherapy work better for some cancers than others?
A powerful tool in modern oncology, immunotherapy doesn’t work the same for everyone. Researchers are exploring why and developing ways to improve its effectiveness.
Read More
The model developed by the Stanford team, which is called SICILIAN, can be integrated into conventional splice alignment tools to detect different RNA variants, such as splice junctions, gene fusions and circular RNA.
Dehghannasin said that the team found that SICILIAN detected gene fusions with similar sensitivity but greater specificity than an existing gene fusion detection tool called STAR-Fusion.

Related Topics

Published In

Volume 16 - Issue 8 | September 2020

September 2020

September 2020 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D molecular visualization of antibody-like protein structures with attached yellow payloads floating against a dark, space-like background.
Evolving approaches to conjugation chemistry and linker–payload design are helping address persistent challenges in bioconjugate development.
Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue